Sprint Bioscience is an agile and innovative company that develops pharmaceuticals in the areas of cancer and metabolism. Since our inception in 2009 we have built a body of solid expertise and achieved a world leading position, thanks to our dedicated and skilled employees and our effective methodology.


Our strategy is to work with a broad portfolio of projects which we quickly develop in the preclinical stage, until we have identified a drug candidate that is ready for clinical trials.

Our goal is to enter into commercial partnerships with larger pharmaceutical companies at an early phase. Our partner then drives the project forward through the clinical phases and onto the market.

We occupy modern laboratories at Novum in Huddinge with access to all the equipment required to pursue advanced drug development.

Sprint Bioscience builds value in drug development by streamlining the process from initial concept to drug candidate.